NUWELLIS, INC. Diluted Shares Outstanding (Weighted Average)
NUWELLIS, INC. (NUWE) reported Diluted Shares Outstanding (Weighted Average) of 181.24 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-13
- NUWELLIS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 181.24K shares, a 2981.84% increase year-over-year.
- NUWELLIS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 2.07M shares, a 1892.41% increase year-over-year.
- NUWELLIS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 1.61M shares.
- NUWELLIS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 836.39K shares, a 308.57% increase year-over-year.
- NUWELLIS, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 690.14K shares, a 2083.93% increase from fiscal 2024.
- NUWELLIS, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 31.60K shares, a 43.70% decline from fiscal 2023.
- NUWELLIS, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 56.13K shares, a 67.72% decline from fiscal 2022.
- NUWELLIS, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 173.85K shares, a 151.95% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 181.24K shares 10-Q · filed 2026-08-13 | 120.26K shares 10-Q · filed 2026-08-13 | 1.29M shares derived: average of 3 quarters · filed 2026-08-13 | 1.18M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | 2.07M shares 10-Q · filed 2026-05-15 | 1.84M shares derived: average of 2 quarters · filed 2026-05-15 | 1.51M shares derived: average of 3 quarters · filed 2026-05-15 | 1.13M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | 1.61M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | 1.23M shares derived: average of 2 quarters · filed 2026-03-11 | 818.83K shares derived: average of 3 quarters · filed 2026-08-13 | 690.14K shares 10-K · filed 2026-03-11 | ||||
| 2025-09-30 | 836.39K shares 10-Q · filed 2025-11-12 | 421.13K shares derived: average of 2 quarters · filed 2026-08-13 | 382.12K shares 10-Q · filed 2025-11-12 | 217.03K shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | 5.88K shares 10-Q · filed 2026-08-13 | 205.84K shares 10-Q · filed 2025-08-14 | 4.43K shares 10-Q · filed 2026-08-13 | 154.99K shares 10-Q · filed 2025-08-14 | 10.57K shares derived: average of 3 quarters · filed 2026-08-13 | 59.11K shares derived: average of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | 104.14K shares 10-Q · filed 2026-05-15 | 4.37M shares 10-Q · filed 2025-05-13 | 12.92K shares derived: average of 2 quarters · filed 2026-05-15 | 76.85K shares derived: average of 3 quarters · filed 2026-05-15 | 60.08K shares derived: average of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | -78.31K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | 63.20K shares derived: average of 2 quarters · filed 2026-03-11 | 45.39K shares derived: average of 3 quarters · filed 2026-03-11 | 31.60K shares 10-K · filed 2026-03-11 | 1.33M shares 10-K · filed 2025-03-11 | |||
| 2024-09-30 | 204.71K shares 10-Q · filed 2025-11-12 | 1.35M shares 10-Q · filed 2024-11-12 | 107.23K shares derived: average of 2 quarters · filed 2025-11-12 | 68.24K shares 10-Q · filed 2025-11-12 | 647.08K shares 10-Q · filed 2024-11-12 | 123.80K shares derived: average of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | 9.76K shares 10-Q · filed 2025-08-14 | 409.69K shares 10-Q · filed 2024-08-13 | 86.26K shares 10-Q · filed 2025-08-14 | 294.65K shares 10-Q · filed 2024-08-13 | 96.83K shares derived: average of 3 quarters · filed 2025-08-14 | 85.94K shares derived: average of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | 179.61K shares 10-Q · filed 2025-05-13 | 6.29M shares 10-Q · filed 2024-05-08 | 140.36K shares derived: average of 2 quarters · filed 2025-05-13 | 111.33K shares derived: average of 3 quarters · filed 2025-05-13 | 92.99K shares derived: average of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | 101.12K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | 77.19K shares derived: average of 2 quarters · filed 2025-03-11 | 64.11K shares derived: average of 3 quarters · filed 2025-03-11 | 56.13K shares 10-K · filed 2025-03-11 | 1.96M shares 10-K · filed 2024-03-11 | |||
| 2023-09-30 | 53.27K shares 10-Q · filed 2024-11-12 | 1.86M shares 10-Q · filed 2023-11-07 | 45.61K shares derived: average of 2 quarters · filed 2024-11-12 | 41.13K shares 10-Q · filed 2024-11-12 | 1.44M shares 10-Q · filed 2023-11-07 | 399.40K shares derived: average of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | 37.95K shares 10-Q · filed 2024-08-13 | 1.33M shares 10-Q · filed 2023-08-08 | 35.06K shares 10-Q · filed 2024-08-13 | 1.23M shares 10-Q · filed 2023-08-08 | 514.78K shares derived: average of 3 quarters · filed 2024-08-13 | 412.33K shares derived: average of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | 1.13M shares 10-Q · filed 2024-05-08 | 1.13M shares 10-Q · filed 2023-05-09 | 753.19K shares derived: average of 2 quarters · filed 2024-05-08 | 537.13K shares derived: average of 3 quarters · filed 2024-05-08 | 429.09K shares derived: average of 4 quarters · filed 2024-05-08 | |||
| 2022-12-31 | 380.38K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | 242.69K shares derived: average of 2 quarters · filed 2024-03-11 | 196.79K shares derived: average of 3 quarters · filed 2024-03-11 | 173.85K shares 10-K · filed 2024-03-11 | 174.00K shares 10-K · filed 2023-03-03 | |||
| 2022-09-30 | 105.00K shares 10-Q · filed 2023-11-07 | 10.54M shares 10-Q · filed 2022-11-08 | 105.00K shares derived: average of 2 quarters · filed 2023-11-07 | 105.00K shares 10-Q · filed 2023-11-07 | 10.54M shares 10-Q · filed 2022-11-08 | -4.07M shares derived: average of 4 quarters · filed 2023-11-07 | ||
| 2022-06-30 | 105.00K shares 10-Q · filed 2023-08-08 | 10.54M shares 10-Q · filed 2022-08-11 | 105.00K shares 10-Q · filed 2023-08-08 | 10.54M shares 10-Q · filed 2022-08-11 | -5.46M shares derived: average of 3 quarters · filed 2023-08-08 | -2.32M shares derived: average of 4 quarters · filed 2023-08-08 | ||
| 2022-03-31 | 105.00K shares 10-Q · filed 2023-05-09 | 10.54M shares 10-Q · filed 2022-05-12 | -8.25M shares derived: average of 2 quarters · filed 2023-05-09 | -3.13M shares derived: average of 3 quarters · filed 2023-05-09 | -715.25K shares derived: average of 4 quarters · filed 2023-05-09 | |||
| 2021-12-31 | -16.60M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | -4.75M shares derived: average of 2 quarters · filed 2023-03-03 | -988.67K shares derived: average of 3 quarters · filed 2023-03-03 | 69.00K shares 10-K · filed 2023-03-03 | 6.85M shares 10-K · filed 2022-03-03 | |||
| 2021-09-30 | 7.10M shares 10-Q · filed 2022-11-08 | 6.82M shares derived: average of 2 quarters · filed 2022-11-08 | 5.62M shares 10-Q · filed 2022-11-08 | 4.90M shares derived: average of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | 6.53M shares 10-Q · filed 2022-08-11 | 4.89M shares 10-Q · filed 2022-08-11 | 4.17M shares derived: average of 3 quarters · filed 2022-08-11 | 3.64M shares derived: average of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | 3.24M shares 10-Q · filed 2022-05-12 | 4.21M shares 10-Q · filed 2021-05-13 | 2.99M shares derived: average of 2 quarters · filed 2022-05-12 | 2.68M shares derived: average of 3 quarters · filed 2022-05-12 | 2.32M shares derived: average of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | 2.73M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | 2.39M shares derived: average of 2 quarters · filed 2022-03-03 | 2.02M shares derived: average of 3 quarters · filed 2022-03-03 | 1.65M shares 10-K · filed 2022-03-03 | ||||
| 2020-09-30 | 2.05M shares 10-Q · filed 2021-11-10 | 1.66M shares derived: average of 2 quarters · filed 2021-11-10 | 1.29M shares 10-Q · filed 2021-11-10 | |||||
| 2020-06-30 | 1.26M shares 10-Q · filed 2021-08-12 | 906.00K shares 10-Q · filed 2021-08-12 | ||||||
| 2020-03-31 | 548.00K shares 10-Q · filed 2021-05-13 | |||||||
| 2012-09-30 | 7.79M shares 10-Q · filed 2012-11-09 | 7.03M shares derived: average of 2 quarters · filed 2012-11-09 | 6.73M shares 10-Q · filed 2012-11-09 | |||||
| 2012-06-30 | 6.28M shares 10-Q · filed 2012-07-30 | 6.22M shares 10-Q · filed 2012-07-30 | ||||||
| 2012-03-31 | 6.17M shares 10-Q · filed 2012-05-14 | |||||||
| 2011-09-30 | 5.58M shares 10-Q · filed 2012-11-09 | 5.33M shares derived: average of 2 quarters · filed 2012-11-09 | 5.25M shares 10-Q · filed 2012-11-09 | |||||
| 2011-06-30 | 5.09M shares 10-Q · filed 2012-07-30 | 5.08M shares 10-Q · filed 2012-07-30 | ||||||
| 2011-03-31 | 5.08M shares 10-Q · filed 2012-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |